Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SCN1A | P35498 | 1/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15728143 | 0.83 | CHRM2 (0.40) | CYP1A2ALDH1A1CYP2C19HRH3HRH1 | |
| SCHEMBL27556133 | 0.82 | SLC6A2 (0.40) | CYP1A2ALDH1A1CYP2C19HRH3HRH1 | |
| SCHEMBL10771160 | 0.81 | HRH1 (0.57) | CYP1A2ALDH1A1CYP2C19HRH3HRH1 | |
| SCHEMBL6938906 | 0.81 | HRH1 (0.57) | CYP1A2ALDH1A1CYP2C19HRH3HRH1 | |
| SCHEMBL574013 | 0.81 | CYP1A2 (0.61) | CYP1A2ALDH1A1CYP2C19HRH3HRH1 | |
| SCHEMBL30201139 | 0.81 | CYP1A2 (0.61) | CYP1A2ALDH1A1CYP2C19HRH3HRH1 | |
| SCHEMBL18598752 | 0.80 | KCNA5 (0.35) | CYP1A2ALDH1A1CYP2C19TSHRCHRM2 | |
| SCHEMBL25447692 | 0.79 | TSHR (0.47) | CYP1A2ALDH1A1CYP2C19HRH3HRH1 | |
| SCHEMBL16477945 | 0.79 | KCNA5 (0.53) | CYP1A2ALDH1A1HRH3HRH1LMNA | |
| SCHEMBL1156021 | 0.79 | KCNA5 (0.53) | CYP1A2ALDH1A1HRH3HRH1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215762-A1 | Siloxane polymer containing tethered levofloxacin | NDSU RESEARCH FOUNDATION | 2009-08-27 | — | — | US | claimed |
| US-8283432-B2 | Siloxane polymer containing tethered fluoroquinolone | NDSU RESEARCH FOUNDATION (US) | 2012-10-09 | — | — | US | disclosed |
| US-8278400-B2 | Antifouling materials containing cationic polysiloxanes | NDSU RESEARCH FOUNDATION (US) | 2012-10-02 | — | — | US | disclosed |
| US-20120046313-A1 | SILOXANE POLYMER CONTAINING TETHERED FLUOROQUINOLONE | NDSU RESEARCH FOUNDATION | 2012-02-23 | — | — | US | disclosed |
| US-20100204399-A1 | ANTIFOULING MATERIALS CONTAINING CATIONIC POLYSILOXANES | NDSU RESEARCH FOUNDATION | 2010-08-12 | — | — | US | disclosed |
| US-7771833-B2 | Anti-fouling materials containing cationic polysiloxanes | NDSU RESEARCH FOUNDATION (US) | 2010-08-10 | — | — | US | disclosed |
| US-20090215762-A1 | Siloxane polymer containing tethered levofloxacin | NDSU RESEARCH FOUNDATION | 2009-08-27 | — | — | US | disclosed |
| EP-1879972-A4 | ANTI-FOULING MATERIALS CONTAINING POLYAMINE CROSS-LINKED POLYSILOXANES | NDSU RES FOUNDATION (US) | 2008-10-15 | — | — | EP | disclosed |
| EP-1879972-A1 | ANTI-FOULING MATERIALS CONTAINING POLYAMINE CROSS-LINKED POLYSILOXANES | NDSU Research Foundation (US) | 2008-01-23 | — | — | EP | disclosed |
| US-20070042199-A1 | Anti-fouling materials containing cationic polysiloxanes | NDSU RESEARCH FOUNDATION | 2007-02-22 | — | — | US | disclosed |
| WO-2006121937-A1 | ANTI-FOULING MATERIALS CONTAINING POLYAMINE CROSS-LINKED POLYSILOXANES | NDSU RESEARCH FOUNDATION (US) | 2006-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046313-A1 | SILOXANE POLYMER CONTAINING TETHERED FLUOROQUINOLONE | QARS1, SEPTIN7, SMCHD1 | CYP1A2 1124/4885ALDH1A1 3261/4885CYP2C19 422/4885 |
| US-20090215762-A1 | Siloxane polymer containing tethered levofloxacin | PUF60, QARS1, SEPTIN7 | CYP1A2 407/4885ALDH1A1 1791/4885CYP2C19 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.